Biotech Company GangaGen raises $1.8mn

Total
0
Shares

Bangalore (and US) based Biotech research company, GangaGen has raised $1.8mn from ATEL ventures.

The funding will be used to develop treatments for antibiotic-resistant bacterial infections like MRSA, a skin infection that plagues hospitals, and pneumonia (via)

Recommended Read: Green Tech Investments in India | The Great Indian Energy Innovation!

Leave a Reply

Sign Up to Newsletter

Daily.

You May Also Like